Article | May 11, 2022

Increasing Diverse Clinical Populations: Sex

Source: THREAD

By Sinead Callinan, Executive Director of Delivery EMEA

GettyImages-1182212179 gender

The lack of representation and diversity in medical research reveals a lack of access to trial participation for many segments of the greater human population. As a result, it can limit the validity and generalizability of conclusions drawn from study data. Attracting a diverse population of patients for a clinical trial is critical to develop effective, safe therapies and long-term population health. Drugs and therapeutics may impact different persons —— in vastly different ways depending on age, race, sex, and other factors. Therefore, trials need to draw on diverse groups of patients to ensure reliable and representative data is collected. This three part series will examine the varied challenges and solutions to increasing diverse clinical populations. In Part I, we’ll look at how research can better address often overlooked gender based differences as an underappreciated variable in the evidence generated in the clinical development lifecycle and why extrapolation of results from one gender to another is objectionable.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader